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INTRODUCTION
The completion of sequencing the 
genomes of a number of organisms 
now provides us with the opportunity 
to understand how these lists of genes 
give rise to cellular behavior governed 
through protein interaction networks. 
Within this framework, one goal of 
proteomics is to classify proteins ac-
cording to their function. In order to do 
this, robust protocols need to be avail-
able that can be applied to large sets of 
molecules. Recently, Ziauddin and col-
leagues (1) have developed such a tool 
for the proteomics field, namely, a mi-
croarray of printed plasmid DNAs for 
reverse transfection of living cells. Such 
microarrays are prepared by first print-
ing a coated glass slide with an array of 
plasmid DNAs. Transfection reagents 
are then overlaid and, finally, cells are 
plated onto these slides, resulting in 
clusters of cells that, with the help of the 
transfection reagent (reverse transfec-
tion), express the respective cDNAs at 
each location. While cDNA overexpres-
sion has certainly enhanced our under-
standing of gene function, the ability to 
selectively down-regulate genes is now 
proving even more powerful. In particu-
lar, RNA interference (RNAi) utilizing 
small interfering RNAs (siRNAs) is a 
recent advance that provides the pos-
sibility of reducing gene expression at 
the post-transcriptional level in cultured 
mammalian cells (2). This technique is 
one valuable step toward determining 
gene function and can be theoretically 
applied on a genome-wide scale (3). 
Here we describe the development, 
testing, and application of a protocol 
for siRNA microarray production that 
allows spotting of the siRNAs and 
transfection reagents in only two steps. 
The procedure is sufficiently robust to 
be applied through automation on a 
large scale to the down-regulation of 
a variety of endogenous proteins. Fur-
thermore, the quality of data obtained 
from this method is ideally suited for 
microscope-based functional assays 





lencia, CA, USA) used for RNAi 
were as follows. For human β-COP 
(GenBank® accession no. NM_




CAGAGUGCCCUUAGCAG-3 ′ ) 
downstream from the ATG. For human 
GM130 (accession no. AF248953; BD 
Biosciences, San Jose, CA, USA), the 
target sequence was 543–563 nucleo-
tides (5′-AAUUACGGAUCAGUUG-
GAAGA-3′), and for human Sec31 
(accession no. AF139184), 529–549 
nucleotides (5′-AACAGACAAGUU-
CAGCAUAUU-3′) downstream from 
the ATG. The target sequence of the 
control oligonucleotide was 5′-AAUU-
CUCCGAACGUGUCACGU-3′. As a 
control, a nonsilencing rhodamine-la-
beled siRNA (si control; si, small inter-
fering) with the sequence 5′-UUCUCC-
GAACGUGUCACG-3′ was used.
In each case, pairs of complemen-
tary RNAs with 3′ dT overhangs were 
synthesized, annealed, and purified. 
Lyophilized oligonucleotide duplexes 
were resuspended in the supplied resus-
pension buffer (Qiagen) at 20 μM. The 
Cy™3-labeled DNA marker oligomer 
with the sequence 5′-TGACGTTC-
TATAGCGACGGCCAGT-3′ was ob-
tained from BioSpring (Frankfurt, Ger-
many). The labeling of oligomers with 
rhodamine or Cy3 was always at the 5′ 
end.
Preparation of Cell Arrays
The siRNA-gelatin transfection so-
lution was prepared in 384-well plates 
(Nalge Nunc International, Rochester, 
NY, USA) as follows. Plasmid (500 ng) 
and/or 1 μL of siRNA solution (20 μM 
in RNA dilution buffer; Qiagen), and 7.5 
μL EC buffer (Qiagen) containing 0.2 
M sucrose were incubated for 10 min at 
room temperature, mixed with 4.5 μL Ef-
fectene® (Qiagen), and incubated for an 
additional 10 min at room temperature 
with 7.25 μL of 0.08% gelatin (Sigma-
Aldrich, St. Louis, MO, USA) and 3.5 × 
10-4% fibronectin (Sigma-Aldrich).
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RNA interference (RNAi) is a recent advance that provides the possibility to reduce the ex-
pression of specific target genes in cultured mammalian cells with potential applications on 
a genome-wide scale. However, to achieve this, robust methodologies that allow automated 
and efficient delivery of small interfering RNAs (siRNAs) into living cultured cells and reli-
able quality control of siRNA function must be in place. Here we describe the production 
of cell arrays for reverse transfection of tissue culture cells with siRNA and plasmid DNA 
suitable for subsequent high-content screening microscopy applications. All the necessary 
transfection components are mixed prior to the robotic spotting on noncoated chambered 
coverglass tissue culture dishes, which are ideally suited for time-lapse microscopy appli-
cations in living cells. The addition of fibronectin to the spotting solution improves cell ad-
herence. After cell seeding, no further cell culture manipulations, such as medium changes 
or the addition of 7serum, are needed. Adaptation of the cell density improves autofocus 
performance for high-quality data acquisition and cell recognition. The co-transfection of a 
nonspecific fluorescently labeled DNA oligomer with the specific siRNA helps to mark each 
successfully transfected cell and cell cluster. We demonstrate such an siRNA cell array in a 
microscope-based functional assay in living cells to determine the effect of various siRNA 
oligonucleotides against endogenous targets on cellular secretion. 
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For transfections with Oligo-
fectamine™ (Invitrogen, La Jolla, CA, 
USA), 1 μL siRNA solution was added 
to 8.5 μL OptiMEM™ (Invitrogen) and 
incubated for 10 min. OptiMEM (1.6 
μL) and 0.4 μL Oligofectamine were 
mixed and incubated for 10 min. These 
two separate solutions were subse-
quently mixed and incubated for anoth-
er 10 min. Then, 8.5 μL of 0.2% gelatin 
and 30 μL of phosphate-buffered saline 
(PBS) were added.
In those experiments where a Cy3-
labeled DNA oligonucleotide was 
used as transfection marker, 0.5 μL of 
a 40-μM marker solution was added 
together with the siRNA or DNA to 
be transfected. The solutions were ar-
rayed onto single-well, chambered 
Lab-Tek™ coverglass tissue culture 
dishes (Nalge Nunc International) us-
ing a ChipWriter™ Compact Robot 
(Bio-Rad Laboratories, Hercules, CA, 
USA). Solid pins (Eurogentec, Sera-
ing, Belgium) and SMP10™ quill pins 
(TeleChem International), resulting in 
a spot diameter of approximately 400 
μm for all experiments, were used. The 
spot volume was approximately 4 nL. 
After printing, 1.25 × 105 HeLa, MCF7, 
COS7L, or HEK293 cells were plated 
on the Lab-Tek slide in a total volume 
of 2.5 mL culture medium [Dulbecco’s 
modified Eagle’s medium (DMEM) 
containing 10% heat-inactivated fetal 
calf serum (FCS), 2 mM glutamine, 
100 U/mL penicillin, and 100 μg/mL 
streptomycin] and incubated for 44 h at 
37°C and 5% CO2.
Immunostaining of Cells and 
Transport Assay
For immunostaining, the cells were 
first fixed in -20°C methanol for 4 min, 
followed by 2 washes with PBS. The 
monoclonal antibody against β-COP 
(mAD; Reference 4) was applied for 
10 min, followed by washing of the 
cells and incubation with anti-mouse 
Alexa488- (Molecular Probes, Eugene, 
OR, USA) or Cy5- (Amersham Bio-
sciences, Piscataway, NJ, USA) con-
jugated secondary antibodies. Finally, 
Hoechst 33342 (1 μg/mL final concen-
tration; Sigma-Aldrich) was added for 
10 min to stain the cell nuclei. For the 
transport assay, cell arrays were pre-
pared as above and then incubated for 
26 h prior to infection with recombinant 
adenoviruses expressing cyan fluores-
cent protein (CFP)-tagged ts-O45-G 
for 1 h, followed by incubation at the 
restrictive temperature of 39.5°C for 16 
h (5). Ts-O45-G was released from the 
endoplasmic reticulum (ER) at 32°C for 
1 h in the presence of 100 μg/mL cy-
cloheximide (Calbiochem, San Diego, 
CA, USA). The cells were fixed with 
3.5% paraformaldehyde for 20 min 
prior to staining with antibodies against 
an extracellular epitope of the ts-O45-G 
protein (4). Secondary antibodies were 
prepared as described above. 
Data Acquisition and Analysis
Images were acquired with Axio 
Vision™ 3.1 on an Axiovert™ 200M 
Microscope (Carl Zeiss, Rochester, 
NY, USA) equipped with a 20×/0.75 
air Fluar® objective (Carl Zeiss) and 
an AxioCam HR™ CCD camera (Carl 
Zeiss). The filters used were standard 
filters (no. 34 for Hoechst, no. 6 for 
CFP, no. 44 for Alexa 488, no. 43 for 
Cy3 and rhodamine, and no. 26 for 
Cy5). Exposure times varied from 57 
ms for Hoechst, 800 ms for CFP, 300 
ms for GFP, and 500 ms for Cy3 and 
rhodamine to 6500 ms for Cy5 and 
were kept constant for all experiments. 
The images were background-cor-
rected by subtracting the average pixel 
value in a blank region of the image. 
Borders of the spot area could be esti-
mated by Cy3 or rhodamine labeling 
of cells (Figure 1A). Transfection effi-
ciencies were then determined by visu-
al inspection and dividing the number 
of successfully transfected cells (indi-
cated by their oligomer-specific Cy3 or 
rhodamine labeling (Figure 1) by the 
total number of cells in a spot area. 
Quantification of single-cell fluo-
rescence was performed with Meta-
Morph® (Universal Imaging, Down-
ingtown, PA, USA). After background 
subtraction, a region around each cell 
of interest was defined manually (radi-
us: 50 image pixels). In each region, the 
average intensity was measured, and 
the mean values with the standard devi-
ation of the means for all regions were 
calculated. Intensities are expressed in 
arbitrary units.
The ts-O45-G transport efficiency 
was calculated by dividing for each cell 
the intensity obtained for the ts-O45-G 
at the cell surface (Cy5) by the intensi-
ty of the CFP-ts-O45-G within the cell. 
The average values obtained were then 
normalized to the si control (1.0) spot-
ted on the same slide.
Western Blot Analysis
HeLa cells were cultured in 6-well 
plates prior to transfection with siRNA 
oligonucleotides against β-COP or 
GM130. For transfections with Oligo-
fectamine, 10 μL siRNA solution were 
added to 170 μL OptiMEM and incu-
bated for 10 min. Sixteen microliters 
of OptiMEM and 4 μL Oligofectamine 
were mixed and incubated for 10 min. 
These two separate solutions were 
subsequently mixed and incubated for 
another 20 min. The cells were washed 
once with serum-free medium and then 
overlaid with 800 μL of the same me-
dium. The transfection mixture was 
added drop-wise to the cells, and then 
incubated for 4 h. Finally, the cells 
were overlaid with 500 μL of medium 
containing 30% serum (10% final con-
centration). After 44 h, the cells were 
lysed in radioimmunoprecipitation 
(RIPA) buffer [50 mM Tris, pH 7.2, 
150 mM NaCl, 1% Triton® X-100, 1% 
sodium deoxycholate, 0.1% sodium do-
decyl sulfate (SDS)], and the total pro-
tein concentrations were determined. 
Twelve micrograms of each extract 
were subjected to sodium dodecyl sul-
fate polyacrylamide gel electrophoresis 
(SDS-PAGE) on 10% gels followed by 
transfer to polyvinylidene difluoride 
(PVDF) membranes. Membranes were 
probed with antibodies against β-COP, 
GM130, or α-tubulin (Neomarkers, 
Fremont, CA, USA), followed by ap-




In order to be able to apply reverse 
transfection to experiments in living 
cells, we decided to use chambered 
coverglass tissue culture dishes for 
spotting the cDNA and siRNA mol-
ecules. These have the advantage that 
they easily permit the cellular medium 
to be changed, facilitate automation of 
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immunostaining protocols and, most 
importantly, allow high-resolution 
functional assays in living cells on any 
inverted microscope.
For array production, we devel-
oped a two-step protocol in which, in 
the first step, the transfection reagent 
used is directly included with a gelatin/
siRNA (DNA)/fibronectin mixture for 
the spotting on uncoated chambered 
coverglass tissue culture dishes. 
The optimal range of fibronectin 
concentration was determined to be be-
tween 3.5 × 10-4% and 5.25 × 10-4%. 
In this range, the transfection efficiency 
increased 1.5-fold, and cell adherence 
2-fold per spot, compared to the same 
solution without fibronectin. We used 
3.5 × 10-4% fibronectin for further ex-
periments.
For a spot diameter of 400 μm and a 
spot-to-spot distance of 1125 μm, one 
can apply 384 samples per Lab-Tek 
chamber. Decreasing the spot-to-spot 
distance to 642 μm allows up to 1176 
spots to be printed on a single Lab-Tek 
slide, thereby accommodating samples 
from more than three 384-well plates.
Reverse transfection by manual 
spotting, for example, into 8-well Lab-
Tek chambers is also possible. Usually, 
we perform this by placing a mask un-
derneath the Lab-Tek chamber to fa-
cilitate a regular spot-to-spot spacing. 
Typical spot volumes are 0.2 μL, and 
about 9 spots can be printed into one of 
the 8-well chambers.
This all-in-one mixture thereby ex-
pedites sample preparation time and 
provides the reagents necessary for cell 
adherence on uncoated glass surfaces. 
In the second step, cells are plated onto 
these arrays in complete growth medi-
um without further changes before data 
acquisition and analyses. In addition, 
we found that this transfection mixture 
is highly suited to a lower density of 
cells than previously used, ultimately 
allowing more detailed image analysis. 
Reducing in this way the reverse trans-
fection protocol to two steps allows 
automation of the entire procedure as 
required for large-scale projects and is 
different from earlier protocols (6,7) 
that involved medium changes or the 
addition of serum. One problem when 
preparing arrays of siRNAs targeting 
endogenous genes is the subsequent 
location of the exact site of the spot-
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ted material. To address this, we either 
used directly labeled siRNAs (Figures 
1–3) or, to make such down-regulation 
cell arrays more universal and less ex-
pensive, unlabeled siRNAs were mixed 
with a nonrelevant Cy3-labeled DNA 
oligonucleotide serving as the transfec-
tion marker. 
In the first phase, we compared 
HeLa, MCF7, COS7L, and HEK293 
cells for their transfection efficien-
cies, growth behavior, and morphology. 
The highest transfection efficiencies 
(>95%) were achieved with HEK293 
cells. However, these cells have the 
disadvantage that they tend to grow on 
top of each other, making automated 
image acquisition and analysis and, in 
particular, focus identification and cell 
segmentation, difficult. In addition, of 
all the cell types tested, they were the 
least adherent, and 24 h after plating 
cells onto spotted siRNAs, they had al-
ready detached. The lowest transfection 
efficiencies (70%) were achieved with 
COS7L cells. With MCF7 and HeLa 
cells, comparable transfection efficien-
cies of 80%–90% were obtained, and 
even 50 h after plating, HeLa cells were 
still highly adherent in the spot areas. 
For subsequent experiments, HeLa 
cells were used.
As a first test of our modified pro-
tocols in applications to down-regulate 
endogenous target genes, we designed 
a number of siRNA oligonucleotides 
against known proteins of the secreto-
ry pathway, including the β subunit of 
the coat protein complex COPI, an es-
sential proteinaceous coat required for 
membrane transport through and the 
integrity of the Golgi complex (8). Cell 
arrays produced with these siRNAs 
were incubated for 44 h before fixing 
and staining with a monoclonal anti-β-
COP antibody to monitor down-regula-
tion of endogenous β-COP in individ-
ual cells. In the cell cluster where the 
β-COP-specific siRNA (siβ-COP161) 
could be visualized in the rhodamine 
(marker) channel, almost no immuno-
staining of the β-COP protein in com-
parison to nontransfected cells outside 
the spot cluster could be observed, in-
dicating effective down-regulation of 
the target protein by the labeled siRNA 
(Figure 1, A–C). In clusters where 
a rhodamine-labeled control siRNA 
known to have no target in mammalian 
cells was transfected, cells appeared to 
have normal β-COP staining, which 
was indistinguishable from those cells 
outside the spot area (Figure 1D). 
Quantification demonstrated that in β-
COP-specific siRNA-transfected cells, 
only about 15% of β-COP-specific 
staining remained compared to control 
transfected cells (Figure 1E). When an 
identical but unlabeled siRNA against 
β-COP was co-transfected with the 
Cy3-labeled marker DNA oligonucleo-
tide, endogenous β-COP was also ef-
ficiently suppressed (Figure 1E), sug-
gesting that the addition of the labeled 
DNA oligonucleotide as a marker for 
the spot and transfected cells has only 
little effect on the uptake and efficacy 
of the target-specific siRNA molecules. 
We performed a control experiment in 
parallel, using “conventional” transfec-
tion of HeLa cells with the siβ-COP161 
oligonucleotides to determine the ex-
tent of down-regulation as determined 
by Western blot analysis. As shown in 
Figure 1F, the levels of β-COP protein 
were reduced to similar levels as that 
observed by the analysis of the cell ar-
ray, while tubulin was unaffected. To-
gether, this indicates that, with respect 
to gene down-regulation, the cell array 
approach gives comparable results to 
biochemical techniques.
We also observed that within the 
global boundary of the spot, a num-
ber of the cells had no detectable rho-
damine fluorescence, although the 
β-COP staining was clearly reduced. 
While measuring these cells, we ob-
served that the average total intensities 
of the β-COP staining was in fact even 
lower than in those cells where the rho-
damine-labeled siRNA molecules were 
still visible (Figure 1E). Because it was 
therefore clear that the down-regula-
tion was also effective in all the cells 
within the global area of the spot, for 
subsequent evaluation we took all the 
cells within this area into account. One 
likely explanation of this visual dispar-
ity is that the rhodamine label of the 
siRNA is partially degraded during 
siRNA processing in the cell. To fur-
ther test the quality of the quantitative 
analysis from such cell arrays, we de-
signed a second siRNA against β-COP 
(siβ-COP1566), which also caused a 
visible reduction in the level of β-COP 
protein; however, the quantification 
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confirmed that this was not as effective 
as the first oligonucleotide siβ-COP161 
(Figure 1E). Therefore, such siRNA 
cell arrays also appear to be a use-
ful means to compare the efficacy of 
multiple siRNA molecules (7). When 
siRNAs against Sec31, a component of 
the COPII complex (9) and against the 
Golgi matrix protein GM130 (10) were 
transfected, little effect on the strength 
of the β-COP staining was observed 
compared to control transfected cells, 
further highlighting the specificity of 
the approach (Figure 1E). The down-
regulation of GM130 and Sec31 was 
however effective in these cells when 
checked by Western blot analysis (Fig-
ure 1F; data not shown).
We next applied the siRNA cell array 
to a functional assay in living cells. In 
particular, we were interested in screen-
ing for the effect of down-regulating 
individual components of the secretory 
pathway on the secretion of a specific 
transport marker. To 
perform this assay, we 
made use of recombi-
nant adenoviruses en-
coding a fluorescently 
tagged temperature-sen-
sitive variant of the viral 
glycoprotein VSV-G 
(ts-O45-G; References 
4 and 11). This marker 
is particularly well 
suited to such assays 
because, at its restric-
tive temperature, it re-
mains misfolded in the 
ER, but on lowering the 
temperature, it is rapid-
ly transported to the cell 
surface. Visual analysis 
of the arrays revealed 
that in the spots con-
taining siRNA against 
β-COP, the transport of 
the ts-O45-G to the cell 
surface was severely 
reduced in many of the 
cells (Figure 2A). In 
contrast, within the spot 
containing the control 
siRNA, the uptake did 
not apparently influ-
ence the transport (Fig-
ure 2B). For each spot, 
the transport efficiency 
was determined and 
thereby a measurement 
of the effectiveness of 
the siRNA in this func-
tional assay. The con-
trol siRNA and DNA 
oligonucleotides alone 
had no significant effect 
on ts-O45-G secretion, 
whereas in the cells de-
pleted of β-COP, trans-
port was reduced to less 
than 40% of the control 
level. Furthermore, even 
in the spot containing 
the less effective siRNA 
against β-COP1566, the 
Figure 1. Specific down-regulation of endogenous β-COP on a small interfering RNA (siRNA) cell array in HeLa 
cells. (A) Example of a 4 × 3 array of rhodamine-labeled siRNA oligonucleotides against β-COP, and (B) their effect on the 
down-regulation of β-COP protein within the limit of the spotted area, as indicated by the dotted line. (C) Further enlarge-
ment of the cells within the area of this spot shows lack of β-COP staining in those cells containing the siRNA molecules, 
(D) whereas within the area of a rhodamine-labeled control (nonsilencing) siRNA spot, normal β-COP staining in those cells 
containing the siRNA molecules is observed. Bars indicate 500 μm in panel A and 10 μm in panels B–D. (E) A quantification 
of the β-COP immunostaining in spots containing siRNA oligonucleotides against various proteins of the secretory pathway. 
L denotes that the oligonucleotides were labeled, U denotes that they were unlabeled but co-transfected with the Cy3 marker 
DNA oligonucleotide, and G denotes that the measurement was made from the global area of the spot. (F) The efficacy of the 
siRNAs against β-COP and GM130 was also confirmed by Western blot analysis. Blots for tubulin from the same cells are 
shown to indicate protein loadings. Oligo, oligonucleotide; si, small interfering; au, arbitrary units.
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transport efficiency was also reduced. 
These data are in good agreement with 
the role of COPI in retrograde transport 
from post-ER membranes (13, and refer-
ences therein), and a reduction of cellu-
lar β-COP levels down to 15% of control 
values should clearly affect ts-O45-G 
transport as observed here. However, 
as β-COP is only indirectly involved in 
anterograde transport, the amounts of 
β-COP in siRNA-treated cells may still 
be enough to allow some ts-O45-G to 
be transported and provides a possible 
explanation for still 40% of ts-O45-G 
arriving at the plasma membrane in our 
experiments at strongly reduced β-COP 
levels. 
Of particular interest, however, 
was that in the spots of siRNA against 
GM130 and Sec31, ts-O45-G transport 
was reduced to approximately 50% of 
control values (Figure 2C). Although 
these results are perhaps not surprising 
because these proteins are important 
components of the secretory pathway, 
they provide evidence that such siRNA 
cell arrays are sufficiently sensitive 
to be used in functional assays such 
as this one to screen large panels of 
siRNA molecules designed against 
endogenous targets.
Finally, we tested our reverse trans-
fection protocol for its ability to be 
able to deliver both DNA and siRNA 
molecules into the same cells. Such a 
possibility is important for large-scale 
screening projects in 
which the cDNA encod-
ing a protein of unknown 
function is available, 
but an antibody is not. 
In such a case, it is im-
perative to know that an 
siRNA targeted against 
the protein of unknown 
function is effectively 
down-regulating the pro-
tein. To demonstrate this, 
we created an array with 
spots containing both a 
cDNA encoding CFP-
β-COP and the corre-
sponding siRNA (Figure 
3). Between 20 and 40 
CFP-β-COP-expressing 
cells were clearly vis-
ible in those spots trans-
fecting either the cDNA 
alone (Figure 3A) or the 
cDNA with the control 
siRNA oligonucleotides 
(Figure 3C). In contrast, 
the expression of CFP-
β-COP was almost not 
detectable when the siβ-
COP161 oligonucleotides 
were co-transfected with 
the CFP-β-COP cDNA 
(Figure 3B). 
Such an siRNA array 
should prove an ideal 
means to utilize the al-
ready available large 
resources of fluores-
cently tagged cDNAs of 
unknown function (see 
http://gfp-cdna.embl.de/; 
Reference 12) in combi-
nation with libraries of 
siRNA molecules, and 
thereby determine siR-
NA efficacy prior to their 
routine use. Together, our 
Figure 2. Use of a small interfering RNA (siRNA) cell array in an assay to measure ts-O45-G transport to the plasma 
membrane in HeLa cells. (A) Images from within a spot of transfected siRNA against β-COP showing the presence of the 
secretory marker ts-O45-G on the cell surface, the total CFP-ts-O45-G in the cells, and the presence of the labeled siRNAs. 
Asterisks mark those cells showing the presence of siRNAs, but no transport of ts-O45-G to the cell surface. (B) Similar ex-
periment as shown in panel A but using a control siRNA. Bars indicate 10 μm. (C) Quantification of ts-O45-G transport to the 
cell surface in spots containing siRNA oligonucleotides against various proteins of the secretory pathway. L denotes that the 
oligonucleotides were labeled, U denotes they were unlabeled but co-transfected with the Cy3 marker DNA oligonucleotide, 
and G denotes that the measurement was made from the global area of the spot. Oligo, oligonucleotide; CFP, cyan fluorescent 
protein; si, small interfering.
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results show that the improved proto-
cols we have developed for the creation 
of cell arrays are highly robust, equally 
applicable to cDNA overexpression and 
siRNA down-regulation, and are suit-
able for application in high-resolution 
functional assays in living cells to deter-
mine protein function. 
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Figure 3. Co-transfection on arrays spotted with cDNA and small interfering RNA (siRNA) mol-
ecules in HeLa cells. (A) Example of a CFP-β-COP-expressing cell in a spot transfected with the 
respective plasmid expression vector only. (B) Cell showing co-transfection of CFP-β-COP and a cor-
responding siRNA, resulting in the lack of cDNA expression. No cells expressing CFP-β-COP could 
be detected in these spots. (C) Cell showing co-transfection of CFP-β-COP and a control siRNA. Bar 
indicates 10 μm. CFP, cyan fluorescent protein.
